Title of project or programme

Communicable diseases – human prion disease and malaria

Principal Investigators of project/programme grant
Title Forname Surname Institution Country
Professor John Collinge MRC Clinical Trials Unit UK
Address of institution of lead PI
Institution MRC Clinical Trials Unit
Street Address 222 Euston Road
City London
Postcode NW1 2DA
Country
  • United Kingdom
Source of funding information

Medical Research Council

Total sum awarded (Euro)

805333.12

Start date of award

01-04-2006

Total duration of award in months

48

The project/programme is most relevant to
  • Prion disease
Keywords
Research abstract in English

Human prion disease: the aim is to assess new therapies for this rapidly progressive fatal disease, and to identify the most appropriate study designs and outcome measures to make these assessments. Randomised controlled trials are difficult to perform and interpret given the small number of affected patients who are often incapacitated, necessitating consent from carers with strong views about the appropriateness of interventions. The first UK treatment study in human disease, PRION-1, was therefore designed as a patient preference trial which allowed individuals to choose to receive quinacrine or not, or to be randomised. The trial finished follow-up in March 2007, and found that randomisation was unacceptable to almost all patients/carers. Final results will be published later this year. A second study of pentosan polysulphate was designed as a clinical review of all UK patients who had received this drug which has to be given intraventricularly. It found that it had been given and tolerated at a very wide range of doses (although complications from the surgical procedures were common) and highlighted the lack of standardised management and monitoring. As a consequence, funding has recently been approved to set up a UK cohort of patients with human prion disease who will be monitored using standardised assessments and schedules, regardless of which interventions they choose to receive.

Lay Summary

Types: Investments > €500k
Member States: United Kingdom
Diseases: Prion disease
Years: 2011
Database Categories: N/A
Database Tags: N/A

Export as PDF